[PDF][PDF] Diet1 functions in the FGF15/19 enterohepatic signaling axis to modulate bile acid and lipid levels

L Vergnes, JM Lee, RG Chin, J Auwerx, K Reue - Cell metabolism, 2013 - cell.com
L Vergnes, JM Lee, RG Chin, J Auwerx, K Reue
Cell metabolism, 2013cell.com
We identified a mutation in the Diet1 gene in a mouse strain that is resistant to
hyperlipidemia and atherosclerosis. Diet1 encodes a 236 kD protein consisting of tandem
low-density lipoprotein receptor and MAM (meprin-A5-protein tyrosine phosphatase mu)
domains and is expressed in the enterocytes of the small intestine. Diet1-deficient mice
exhibited an elevated bile acid pool size and impaired feedback regulation of hepatic
Cyp7a1, which encodes the rate-limiting enzyme in bile acid synthesis. In mouse intestine …
Summary
We identified a mutation in the Diet1 gene in a mouse strain that is resistant to hyperlipidemia and atherosclerosis. Diet1 encodes a 236 kD protein consisting of tandem low-density lipoprotein receptor and MAM (meprin-A5-protein tyrosine phosphatase mu) domains and is expressed in the enterocytes of the small intestine. Diet1-deficient mice exhibited an elevated bile acid pool size and impaired feedback regulation of hepatic Cyp7a1, which encodes the rate-limiting enzyme in bile acid synthesis. In mouse intestine and in cultured human intestinal cells, Diet1 expression levels influenced the production of fibroblast growth factor 15/19 (FGF15/19), a hormone that signals from the intestine to liver to regulate Cyp7a1. Transgenic expression of Diet1, or adenoviral-mediated Fgf15 expression, restored normal Cyp7a1 regulation in Diet-1-deficient mice. Diet1 and FGF19 proteins exhibited overlapping subcellular localization in cultured intestinal cells. These results establish Diet1 as a control point in enterohepatic bile acid signaling and lipid homeostasis.
cell.com